» Articles » PMID: 34134879

Trends in Visits to Substance Use Disorder Treatment Facilities in 2020

Overview
Specialty Psychiatry
Date 2021 Jun 17
PMID 34134879
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To describe weekly changes in the number of substance use disorder treatment (SUDT) facility visits in 2020 compared to 2019 using cell phone location data.

Methods: We calculated the percentage weekly change in visits to SUDT facilities from the week of January 5 through the week of October 11, 2020, relative to the week of January 6 through the week of October 13, 2019. We stratified facilities by county COVID-19 incidence per 10,000 residents in each week and by 2018 fatal drug overdose rate. Finally, we conducted a multivariable linear regression analysis examining percent change in visits per week as a function of county-level COVID-19 tercile, a series of calendar month indicators, and the interaction of county-level COVID-19 tercile and month. We repeated the regression analysis replacing COVID-19 tercile with overdose tercile.

Results: Beginning the eleventh week of 2020, the number of visits to SUDT facilities declined substantially, reaching a nadir of 48% of 2019 visits in early July. In contrast to January, there were significantly fewer visits in 2020 compared to 2019 in all subsequent months (p < 0.01 in all months). Multivariable regression results found that facilities in the tercile of counties experiencing the most COVID-19 cases had a significantly greater reduction in the number of SUDT visits in 2020 for the months of June through August than facilities in counties with the fewest COVID-19 rates (p < 0.05). The study found no statistically significant difference in the change in the number of visits by facilities in counties with historically different overdose rates.

Discussion: Our findings support the hypothesis that a reduction has occurred in the average weekly number of visits to SUDT facilities. The size of the effect differs based on the number of COVID-19 cases but not on historical overdose rate.

Citing Articles

Substance Use Disorder Treatment Programs during a Health Crisis: Response to the COVID-19 Pandemic and Future Implications.

Baloh J, Charton H, Curran G Subst Use Misuse. 2023; 58(14):1855-1865.

PMID: 37722809 PMC: 10872742. DOI: 10.1080/10826084.2023.2257305.


Trends in self-reported non-fatal overdose and patterns of substance use before and during the COVID-19 pandemic in a prospective cohort of adults who have injected drugs - Baltimore, Maryland, 2014-2022.

Feder K, Patel E, Buresh M, Kirk G, Mehta S, Genberg B Drug Alcohol Depend. 2023; 251:110954.

PMID: 37716287 PMC: 10538370. DOI: 10.1016/j.drugalcdep.2023.110954.


Reductions in anxiety and depression symptoms in a subset of outpatients with problematic substance use who received ketamine-assisted psychotherapy: a two-year retrospective chart review.

Whinkin E, Eparwa T, Julseth M, Schneider A, Aggarwal S Front Psychiatry. 2023; 14:1160442.

PMID: 37711421 PMC: 10498542. DOI: 10.3389/fpsyt.2023.1160442.


Identifying biomarkers of drug use recurrence using wearable device technologies and phone applications.

Mahoney 3rd J, Finomore V, Marton J, Ramadan J, Hodder S, Thompson-Lake D Drug Alcohol Depend. 2023; 249:110817.

PMID: 37331302 PMC: 10416187. DOI: 10.1016/j.drugalcdep.2023.110817.


Association between immigrant concentration and mental health service utilization in the United States over time: A geospatial big data analysis.

Jing F, Li Z, Qiao S, Ning H, Zhou S, Li X Health Place. 2023; 83:103055.

PMID: 37311276 PMC: 10527759. DOI: 10.1016/j.healthplace.2023.103055.


References
1.
Allcott H, Boxell L, Conway J, Gentzkow M, Thaler M, Yang D . Polarization and public health: Partisan differences in social distancing during the coronavirus pandemic. J Public Econ. 2020; 191:104254. PMC: 7409721. DOI: 10.1016/j.jpubeco.2020.104254. View

2.
Gupta S, Montenovo L, Nguyen T, Lozano-Rojas F, Schmutte I, Simon K . Effects of social distancing policy on labor market outcomes. Contemp Econ Policy. 2023; 41(1):166-193. PMC: 10635474. DOI: 10.1111/coep.12582. View

3.
Cantor J, Stein B, Saloner B . Telehealth Capability Among Substance Use Disorder Treatment Facilities in Counties With High Versus Low COVID-19 Social Distancing. J Addict Med. 2020; 14(6):e366-e368. PMC: 7869724. DOI: 10.1097/ADM.0000000000000744. View

4.
Cantor J, Sood N, Bravata D, Pera M, Whaley C . The impact of the COVID-19 pandemic and policy response on health care utilization: Evidence from county-level medical claims and cellphone data. J Health Econ. 2022; 82:102581. PMC: 8755425. DOI: 10.1016/j.jhealeco.2022.102581. View

5.
Samuels E, Clark S, Wunsch C, Jordison Keeler L, Reddy N, Vanjani R . Innovation During COVID-19: Improving Addiction Treatment Access. J Addict Med. 2020; 14(4):e8-e9. PMC: 7236851. DOI: 10.1097/ADM.0000000000000685. View